Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,675,542
-$4,941,011 QoQ
Shares Held
360,280
-25.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#451
of 2,834 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Sep 30, 2025CallValue
$10,192
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $318,890,544 across 18 Drug Manufacturers - General names. PFE ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
362,958 | $92,180,442 | |
| 2 | LLY |
ELI LILLY & Co
|
68,037 | $81,605,624 | |
| 3 | ABBV |
AbbVie Inc.
|
222,751 | $56,053,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
208,546 | $26,798,161 | |
| 5 | AMGN |
Amgen Inc
|
53,858 | $19,503,058 | |
| 6 | NVS |
Novartis AG
|
92,390 | $14,479,360 | |
| 7 | PFE |
Pfizer Inc
This page
|
360,280 | $8,675,542 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
129,525 | $7,463,230 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,675,542 | 360,280 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $13,616,553 | 484,920 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,879,189 | 356,594 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $10,192 | 400 | Call | Sole | 2025-12-02 | |
| 2025-09-30 | $5,539,097 | 217,390 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $5,295,203 | 218,449 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,857,761 | 152,240 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,526,685 | 132,932 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,407,829 | 117,755 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $3,157,262 | 112,840 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,863,938 | 103,205 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,847,244 | 98,897 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,828,049 | 115,407 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,243,031 | 115,677 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $4,535,204 | 111,157 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $5,714,950 | 111,533 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,440,502 | 101,474 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,833,049 | 92,181 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $3,704,868 | 71,564 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $3,389,765 | 57,405 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,374,668 | 55,212 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,381,643 | 35,282 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,331,017 | 36,738 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,110,557 | 30,170 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $994,495 | 27,098 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $807,429 | 24,692 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $629,298 | 19,280 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||